REVVITY, INC Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
REVVITY, INC (RVTY) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of -$291.00 thousand for the 12-month period ending 2017-01-01, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2017-02-28
- REVVITY, INC effective income tax rate reconciliation, tax contingency, amount for fiscal 2017 was -$291.00K.
- REVVITY, INC effective income tax rate reconciliation, tax contingency, amount for fiscal 2016 was -$5.34M.
- REVVITY, INC effective income tax rate reconciliation, tax contingency, amount for fiscal 2014 was -$7.61M.
- REVVITY, INC effective income tax rate reconciliation, tax contingency, amount for fiscal 2013 was -$34.45M, a 2593.13% decline from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2017-01-01 | -$291.00K 10-K · filed 2017-02-28 |
| 2016-01-03 | -$5.34M 10-K · filed 2017-02-28 |
| 2014-12-28 | -$7.61M 10-K · filed 2017-02-28 |
| 2013-12-29 | -$34.45M 10-K · filed 2016-03-01 |
| 2012-12-30 | $1.38M 10-K · filed 2015-02-24 |
| 2012-01-01 | $5.48M 10-K · filed 2014-02-25 |
| 2011-01-02 | -$7.67M 10-K · filed 2013-02-26 |
| 2010-01-03 | $577.00K 10-K · filed 2012-02-28 |
| 2008-12-28 | -$7.26M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |